The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Outcome and Predictors of Treatment Failure in Total Hip/Knee Prosthetic Joint Infections Due to Staphylococcus aureus
Open accessAbstract
BACKGROUND: Variables associated with the outcome of patients treated for prosthetic joint infections (PJIs) due to Staphylococcus aureus are not well known. METHODS: The medical records of patients treated surgically for total hip or knee prosthesis infection due to S. aureus were reviewed. Remission was defined by the absence of local or systemic signs of implant-related infection assessed during the most recent contact with the patient. RESULTS: After a mean posttreatment follow-up period of 43.6 ± 32.1 months, 77 (78.6%) of 98 patients were in remission. Retention of the infected implants was not associated with a worse outcome than was their removal. Methicillin-resistant S. aureus (MRSA)-related PJIs were not associated with worse outcome, compared with methicillin-susceptible S. aureus (MSSA)-related PJIs. Pathogens identified during revision for failure exhibited no acquired resistance to antibiotics used as definitive therapy, in particular rifampin. In univariate analysis, parameters that differed between patients whose treatment did or did not fail were: American Society of Anesthesiologists (ASA) score, prescription of adequate empirical postsurgical antibiotic therapy, and use of rifampin combination therapy upon discharge from hospital. In multivariate analysis, ASA score ≤2 (odds ratio [OR], 6.87 [95% confidence interval {CI}, 1.45-32.45]; P = .04) and rifampin-fluoroquinolone combination therapy (OR, 0.40 [95% CI, 0.17-0.97]; P = .01) were 2 independent variables associated with remission. CONCLUSIONS: The results of the present study suggest that the ASA score significantly affects the outcome of patients treated for total hip and knee prosthetic infections due to MSSA or MRSA and that rifampin combination therapy is associated with a better outcome for these patients when compared with other antibiotic regimens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Projections of Primary and Revision Hip and Knee Arthroplasty in the United States from 2005 to 2030
Kurtz, S., Ong, K., Lau, E., Mowat, F., & Halpern, M. (2007) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200704000-00012 · Cited by 8,698
Zimmerli, W., Trampuz, A., & Ochsner, P. E. (2004) · New England Journal of Medicine · doi:10.1056/nejmra040181 · Cited by 3,116
Zimmerli, W. (1998) · JAMA · doi:10.1001/jama.279.19.1537 · Cited by 1,079
Infection after Total Hip Arthroplasty. A Study of the Treatment of One Hundred and Six Infections*
TSUKAYAMA, D. T., ESTRADA, R., & GUSTILO, R. B. (1996) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-199604000-00005 · Cited by 957
Infections Associated with Indwelling Medical Devices
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-5-391_2 · Cited by 537
Treatment of Infection with Débridement and Retention of the Components following Hip Arthroplasty*
CROCKARELL, J. R., HANSSEN, A. D., OSMON, D. R., & MORREY, B. F. (1998) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-199809000-00009 · Cited by 308
Two-stage reconstruction of a total hip arthroplasty because of infection.
McDonald, D. J., Fitzgerald, R. H., & Ilstrup, D. M. (1989) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-198971060-00005 · Cited by 276
Moran, E., Masters, S., Berendt, A. R., McLardy-Smith, P., Byren, I., & Atkins, B. L. (2007) · Journal of Infection · doi:10.1016/j.jinf.2007.01.007 · Cited by 260
Higher Risk of Failure of Methicillin-resistant Staphylococcus aureus Prosthetic Joint Infections
Salgado, C. D., Dash, S., Cantey, J. R., & Marculescu, C. E. (2007) · Clinical Orthopaedics & Related Research · doi:10.1097/blo.0b013e3181123d4e · Cited by 254
Antimicrobial Treatment of Orthopedic Implant-related Infections with Rifampin Combinations
Widmer, A. F., Gaechter, A., Ochsner, P. E., & Zimmerli, W. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.6.1251 · Cited by 253
Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants
Drancourt, M., Stein, A., Argenson, J. N., Zannier, A., Curvale, G., & Raoult, D. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.6.1214 · Cited by 252
Management of Infection Associated with Total Hip Arthroplasty according to a Treatment Algorithm
Giulieri, S. G., Graber, P., Ochsner, P. E., & Zimmerli, W. (2004) · Infection · doi:10.1007/s15010-004-4020-1 · Cited by 237
(1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/33.5.959 · Cited by 192
Fisman, D. N., Reilly, D. T., Karchmer, A. W., & Goldie, S. J. (2001) · Clinical Infectious Diseases · doi:10.1086/318502 · Cited by 191
Conservative Treatment of Staphylococcal Prosthetic Joint Infections in Elderly Patients
Barberán, J., Aguilar, L., Carroquino, G., Giménez, M.-J., Sánchez, B., Martínez, D., & Prieto, J. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.036 · Cited by 187
Vílchez‐Cavazos, F., Martinez-Pastor, J. C., García-Ramiro, S., Bori, G., Maculé, F., Sierra, J. M., Font, L., Mensa, J., & Soriano, À. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03244.x · Cited by 153
Choong, P., Dowsey, M. M., Carr, D., Daffy, J. R., & Stanley, P. A. (2007) · Acta Orthopaedica · doi:10.1080/17453670710014527 · Cited by 151
Stein, A., Bataille, J. F., Drancourt, M., Curvale, G., Argenson, J., Groulier, P., & Raoult, D. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.12.3086 · Cited by 150
Chuard, C., Herrmann, M., Vaudaux, P., Waldvogel, F. A., & Lew, D. P. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.12.2611 · Cited by 143
Treatment of infected retained implants
Trebše, R., Pišot, V., & Trampuž, A. (2005) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.87b2.15618 · Cited by 143
Helou, O. C. E., Berbari, E. F., Lahr, B. D., Eckel‐Passow, J. E., Razonable, R. R., Sia, I. G., Virk, A., Walker, R. C., Steckelberg, J. M., Wilson, W. R., et al. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-0952-9 · Cited by 129
Ferry, T., Uçkay, İ., Vaudaux, P. E., François, P., Schrenzel, J., Harbarth, S., Laurent, F. J., Bernard, L., Vandenesch, F., Étienne, J., et al. (2009) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-009-0837-y · Cited by 70
Cited by
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Tande, A. J., & Patel, R. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00111-13 · Cited by 1,885
Periprosthetic joint infection
Kapadia, B. H., Berg, R. A., Daley, J. A., Fritz, J., Bhave, A., & Mont, M. A. (2016) · The Lancet · doi:10.1016/s0140-6736(14)61798-0 · Cited by 929
Li, B., & Webster, T. J. (2018) · Journal of Orthopaedic Research · doi:10.1002/jor.23656 · Cited by 907
Chakfé, N., Diener, H., Lejay, A., Assadian, O., Berard, X., Caillon, J., Fourneau, I., Glaudemans, A. W. J. M., Koncar, I., Lindholt, J., et al. (2020) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2019.10.016 · Cited by 563
Self-citation
Metadata
- Authors
- Senneville, E., Joulie, D., Legout, L., Valette, M., Dezeque, H., Beltrand, E., Rosele, B., d'Escrivan, T., Loiez, C., Caillaux, M., Yazdanpanah, Y., Maynou, C., & Migaud, H.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-08-01
- Volume
- 53
- Issue
- 4
- Pages
- 334-340
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2075621134
- Cited by
- 255
- References
- 22
- FWCI
- 16.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.